Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Prieto-Alhambra"'
Autor:
Albert Prats-Uribe, Spyros Kolovos, Klara Berencsi, Andrew Carr, Andrew Judge, Alan Silman, Nigel Arden, Irene Petersen, Ian J Douglas, J Mark Wilkinson, David Murray, Jose M Valderas, David J Beard, Sarah E Lamb, M Sanni Ali, Rafael Pinedo-Villanueva, Victoria Y Strauss, Daniel Prieto-Alhambra
Publikováno v:
Health Technology Assessment, Vol 25, Iss 66 (2021)
Background: Although routine NHS data potentially include all patients, confounding limits their use for causal inference. Methods to minimise confounding in observational studies of implantable devices are required to enable the evaluation of patien
Externí odkaz:
https://doaj.org/article/08119d74bbdd4f1f89c190f51944fe4c
Autor:
Danielle E Robinson, M Sanni Ali, Victoria Y Strauss, Leena Elhussein, Bo Abrahamsen, Nigel K Arden, Yoav Ben-Shlomo, Fergus Caskey, Cyrus Cooper, Daniel Dedman, Antonella Delmestri, Andrew Judge, Muhammad Kassim Javaid, Daniel Prieto-Alhambra
Publikováno v:
Health Technology Assessment, Vol 25, Iss 17 (2021)
Background: Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects. Ob
Externí odkaz:
https://doaj.org/article/77eb4161572b4beeac2b52a659bf4038
Autor:
Jonathan L Rees, Anjali Shah, Katherine Edwards, Maria T Sanchez-Santos, Danielle E Robinson, Antonella Delmestri, Andrew Carr, Nigel Arden, Sarah E Lamb, Amar Rangan, Andrew Judge, Rafael Pinedo-Villanueva, Tim Holt, Sally Hopewell, Daniel Prieto-Alhambra, Gary Collins
Publikováno v:
Health Technology Assessment, Vol 23, Iss 18 (2019)
Background: Shoulder dislocations are the most common joint dislocations seen in emergency departments. Most traumatic cases are anterior and cause recurrent dislocations. Management options include surgical and conservative treatments. There is a la
Externí odkaz:
https://doaj.org/article/7f2c1835a2104b8a9811318c71b1347a
Autor:
M Sanni Ali, Daniel Dedman, Leena Elhussein, Nigel K Arden, Danielle E Robinson, Andrew Judge, Yoav Ben-Shlomo, Bo Abrahamsen, Muhammad Javaid, Daniel Prieto-Alhambra, Victoria Y Strauss, Antonella Delmestri, Cyrus Cooper, Fergus Caskey
Publikováno v:
Health Technology Assessment, Vol 25, Iss 17 (2021)
Robinson, D E, Sanni Ali, M, Strauss, V, Elhussein, L, Abrahamsen, B, Arden, N K, Ben-Shlomo, Y, Caskey, F J, Cooper, C, Dedman, D J, Delmestri, A, Judge, A, Javaid, M K & Prieto-Alhambra, D 2021, ' Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease : a propensity-score matched cohort study ', Health Technology Assessment, vol. 25, no. 17, pp. i-xxviii, 1-105 . https://doi.org/10.3310/hta25170
Health Technol Assess
Robinson, D E, Ali, M S, Strauss, V Y, Elhussein, L, Abrahamsen, B, Arden, N K, Ben-Shlomo, Y, Caskey, F, Cooper, C, Dedman, D, Delmestri, A, Judge, A, Javaid, M K & Prieto-Alhambra, D 2021, ' Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease : a propensity score-matched cohort study ', Health Technology Assessment, vol. 25, no. 17 . https://doi.org/10.3310/hta25170
Robinson, D E, Sanni Ali, M, Strauss, V, Elhussein, L, Abrahamsen, B, Arden, N K, Ben-Shlomo, Y, Caskey, F J, Cooper, C, Dedman, D J, Delmestri, A, Judge, A, Javaid, M K & Prieto-Alhambra, D 2021, ' Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease : a propensity-score matched cohort study ', Health Technology Assessment, vol. 25, no. 17, pp. i-xxviii, 1-105 . https://doi.org/10.3310/hta25170
Health Technol Assess
Robinson, D E, Ali, M S, Strauss, V Y, Elhussein, L, Abrahamsen, B, Arden, N K, Ben-Shlomo, Y, Caskey, F, Cooper, C, Dedman, D, Delmestri, A, Judge, A, Javaid, M K & Prieto-Alhambra, D 2021, ' Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease : a propensity score-matched cohort study ', Health Technology Assessment, vol. 25, no. 17 . https://doi.org/10.3310/hta25170
Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects.The aims of eac